Medite Cancer Diagnostics, Inc.
MDIT
$0.00
$0.000.00%
| 09/30/2018 | 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | |
|---|---|---|---|---|---|
| Net Income | -735.00K | -563.00K | -1.40M | -2.63M | -1.61M |
| Total Depreciation and Amortization | 62.00K | 68.00K | 71.00K | 80.00K | 110.00K |
| Total Amortization of Deferred Charges | 309.00K | 236.00K | 177.00K | 127.00K | 7.00K |
| Total Other Non-Cash Items | 42.00K | 42.00K | 43.00K | 129.00K | 347.00K |
| Change in Net Operating Assets | -499.00K | -798.00K | -530.00K | 576.00K | 678.00K |
| Cash from Operations | -821.00K | -1.02M | -1.64M | -1.71M | -463.00K |
| Capital Expenditure | -11.00K | -2.00K | -2.00K | -91.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11.00K | -2.00K | -2.00K | -91.00K | -16.00K |
| Total Debt Issued | 930.00K | 930.00K | 1.46M | 316.00K | 4.67M |
| Total Debt Repaid | -31.00K | -43.00K | -36.00K | -490.00K | -2.61M |
| Issuance of Common Stock | -- | -- | -- | 187.00K | 319.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -211.00K | -- |
| Cash from Financing | 899.00K | 887.00K | 1.43M | -198.00K | 2.38M |
| Foreign Exchange rate Adjustments | -2.00K | -35.00K | -28.00K | 422.00K | -261.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.00K | -165.00K | -243.00K | -1.58M | 1.64M |
